References
  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68: 394-424. doi:10.3322/caac.21492.
  2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019; 69: 7-34. doi:10.3322/caac.21551
  3. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66; 115-32. doi:10.3322/caac.21338.
  4. Joly F, Hilpert F, Okamoto A, Stuart G, Ochiai K, Friedlander M. Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: Recommendations on incorporating patient-reported outcomes in clinical trials in epithelial ovarian cancer. Eur J Cancer. 2017; 78: 133-138. doi:10.1016/j.ejca. 2017.03.019.
  5. Koster EB, Baars EW, Delnoij DM. Patient-centered outcomes on quality of life and anthroposophic healthcare: a qualitative triangulation study. Qual Life Res. 2016; 25: 2257–2267. doi:10.1007/s11136-016-1276-8.
  6. Westin SN, Sun CC, Tung CS, Lacour RA, Meyer LA, Urbauer DL, et al. Survivors of gynecologic malignancies: impact of treatment on health and well-being. J Cancer Surviv. 2016; 10: 261-70. doi: 10.1007/s11764-015-0472-9.
  7. Barnaś E, Skręt-Magierło J, Skręt A, Bidziński M. The quality of life of women treated for cervical cancer. Eur J Oncol Nurs. 2012; 16: 59-63. doi:10.1016/j.ejon.2011.03.001.
  8. Pulgar Á, Alcalá A, Reyes Del Paso, GA. Psychosocial predictors of quality of life in hematological cancer. Behav Med. 2015; 41: 1-8. doi: 10.1080/08964289.2013.833083.
  9. Bail JR, Traeger L, Pirl WF, Bakitas MA. Psychological Symptoms in Advanced Cancer. Semin Oncol Nurs. 2018; 34: 241-251. doi: 10.1016/j.soncn.2018.06.005.
  10. Vodermaier A, Linden W, MacKenzie R, Greig D, Marshall C. Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer. Br J Cancer. 2011; 105: 1814-7. doi: 10.1038/bjc.2011.503.
  11. Kelly K, Posternak M, Alpert JE. Toward achieving optimal response: understanding and managing antidepressant side effects. Dialogues Clin Neurosci. 2008; 10: 409-18. doi:10.31887/ DCNS.2008.10.4/kkelly.
  12. Brown LF, Kroenke K, Theobald DE, Wu J, Tu W. The association of depression and anxiety with health-related quality of life in cancer patients with depression and/or pain. Psychooncology. 2010; 19: 734-41. doi: 10.1002/pon.1627.
  13. Pitman A, Suleman S, Hyde N, Hodgkiss A. Depression and anxiety in patients with cancer. BMJ.2018; 361: k1415. doi: 10.1136/bmj.k1415.
  14. Linden W, Vodermaier A, Mackenzie R, Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. Journal Of Affective Disorders.2012; 141: 343-351.doi: 10.1016/j.jad.2012.03.025.
  15. Miller S, Lo C, Gagliese L, Hales S, Rydall A, Zimmermann C, et al. Patterns of depression in cancer patients: an indirect test of gender-specific vulnerabilities to depression. Soc Psychiatry Psychiatr Epidemiol. 2011; 46: 767-74. doi: 10.1007/s00127-010-0246-7.
  16. Borji M, Nourmohammadi H, Otaghi M, Salimi AH, Tarjoman A. Positive Effects of Cognitive Behavioral Therapy on Depression, Anxiety and Stress of Family Caregivers of Patients with Prostate Cancer: A Randomized Clinical Trial. Asian Pac J Cancer Prev. 2017;18: 3207-3212. doi: 10.22034/APJCP.2017.18.12.3207
  17. Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011; 12: 160-74. doi:10. 1016/S1470-2045(11)70002-X.
  18. Pascoe S, Edelman S, Kidman A. Prevalence of psychological distress and use of support services by cancer patients at Sydney hospitals. Aust N Z J Psychiatry. 2000; 34: 785-91. doi:10. 1080/j.1440-1614.2000.00817.x.
  19. Murphy MJ, Newby JM, Butow P, Kirsten L, Allison K, Loughnan S, et al. Correction to: i Can ADAPT early protocol: randomised controlled trial (RCT) of clinician supervised transdiagnostic internet-delivered cognitive behaviour therapy (iCBT) for depression and/or anxiety in early stage cancer survivors -vs- treatment as usual. BMC Cancer. 2017; 17: 667. doi: 10.1186/s12885-017-3655-0.
  20. He Y, Jian H, Yan M, Zhu J, Li G, Lou VWQ, et al. Coping, mood and health-related quality of life: a cross-sectional study in Chinese patients with advanced lung cancer. BMJ Open.2019; 9: e023672. doi: 10.1136/bmjopen-2018-023672.
  21. Hajian-Tilaki K, Heidari B, Hajian-Tilaki A. Solitary and combined negative influences of diabetes, obesity and hypertension on health-related quality of life of elderly individuals: A population-based cross-sectional study. Diabetes Metab Syndr. 2016; 10: S37-42. doi:10. 1016/j.dsx.2016.01.018.
  22. Le Roux S, Lotter GA, Steyn HS, Malan L. Cultural coping as a risk for depression and hypertension: the SABPA prospective study. Cardiovasc J Afr. 2018; 29: 366-373. doi:10.5830/CVJ A-2018-045.
  23. Kretchy IA, Owusu-Daaku FT, Danquah SA. Mental health in hypertension: assessing symptoms of anxiety, depression and stress on anti-hypertensive medication adherence. Int J Ment Health Syst. 2014; 8: 25. doi: 10.1186/1752-4458-8-25.
  24. Byrd JB, Powers JD, Magid DJ, Tavel HM, Schmittdiel JA, O’Connor PJ, et al. Detection and recognition of hypertension in anxious and depressed patients. J Hypertens.2012; 30: 2293-8. doi: 10.1097/HJH.0b013e328359b6e6.
  25. Goldberg RW, Rollins AL, Lehman AF. Social network correlates among people with psychiatric disabilities. Psychiatr Rehabil J.2003; 26: 393-402. doi: 10.2975/26.2003.393.402.
  26. Brailovskaia J, Schönfeld P, Zhang XC, Bieda A, Kochetkov Y, Margraf J. A Cross-Cultural Study in Germany, Russia, and China: Are Resilient and Social Supported Students Protected Against Depression, Anxiety, and Stress? Psychol Rep. 2018; 121: 265-281. doi:10.1177/00332 94117727745.
  27. Huang CY, Hsu MC. Social support as a moderator between depressive symptoms and quality of life outcomes of breast cancer survivors. Eur J Oncol Nurs. 2013; 17: 767-74. doi:10.1016/ j.ejon.2013.03.011.
  28. Panayiotou G, Karekla M. Perceived social support helps, but does not buffer the negative impact of anxiety disorders on quality of life and perceived stress. Soc Psychiatry Psychiatr Epidemiol. 2013; 48: 283-94. doi: 10.1007/s00127-012-0533-6.
  29. Cohen S, Wills TA. Stress, social support, and the buffering hypothesis. Psychol Bull. 1985; 98: 310-57. doi:10.1037/0033-2909.98.2.310
  30. Zung WW. The measurement of affects: depression and anxiety. Mod Probl Pharmacopsychiatry. 1974; 7: 170-88. doi: 10.1159/000395075.
  31. Zung WW. How normal is anxiety? Upjohn: Durham. 1980.
  32. Zung WW. From art to science. The diagnosis and treatment of depression. Arch Gen Psychiatry. 1973; 29: 328-37. doi: 10.1001/archpsyc.1973.04200030026004.
  33. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993; 11: 570-9. doi:10.1200/JCO.1993. 11.3.570.
  34. Zimet GD, Dahlem NM, Zimet SG, Farley GK. The Multidimensional Scale of Perceived Social Support. Journal of Personality Assessment. 1988; 52: 30-41. doi:10.1207/s15327752 jpa5201_2.
  35. Andersson T, Alfredsson L, Källberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol. 2005; 20: 575-9. doi: 10.1007/s10654-005-7835-x.
  36. Rothman KJ, Greenland S. Modem epidemiology. 2nd eds. Philadelphia:A Wohers Kluwer Company. 1998; 329-342.
  37. Rothman KJ. Epidemiology: 8n introduction. New York:Oxford University Press.2002; 168-180.
  38. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology. 1992; 3: 452-6. doi: 10.1097/00001648-199209000-00012.
  39. Bolin JH. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach. Journal of Educational Measurement. 2014; 51: 335-337. doi:10.11 11/jedm.12050
  40. Lim JK, Cronkite R, Goldstein MK, Cheung RC. The impact of chronic hepatitis C and comorbid psychiatric illnesses on health-related quality of life. J Clin Gastroenterol. 2006; 40: 528-34. doi: 10.1097/00004836-200607000-00012.
  41. Sareen J, Jacobi F, Cox BJ, Belik SL, Clara I, Stein MB. Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions. Arch Intern Med. 2006; 166: 2109-16. doi: 10.1001/archinte.166.19.2109.
  42. Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJ, Goodwin RD, Kubzansky L, et al. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry. 2008; 30: 208-25. doi:10.1016/j.genhosppsych.2007.12. 006.
  43. Pinquart M, Duberstein PR. Depression and cancer mortality: a meta-analysis. Psychol Med. 2010; 40: 1797-810. doi: 10.1017/S0033291709992285.
  44. Li W, Liu L, Puente JG, Li Y, Jiang X, Jin S, et al. Hypertension and health-related quality of life: an epidemiological study in patients attending hospital clinics in China. J Hypertens. 2005; 23: 1667-76. doi:10.1097/01.hjh.0000174 971.64589.39.
  45. Carroll D, Phillips AC, Gale CR, Batty GD. Generalized anxiety and major depressive disorders, their comorbidity and hypertension in middle-aged men. Psychosom Med. 2010; 72: 16-9. doi: 10.1097/PSY.0b013e3181c4fca1.
  46. Hamer M, Batty GD, Stamatakis E, Kivimaki M. Hypertension awareness and psychological distress. Hypertension. 2010; 56:547-50.doi:10.1161/HYPERTENSIONAHA.110.153775.
  47. Green AJ, Bazata DD, Fox KM, Grandy S. Quality of Life, Depression, and Healthcare Resource Utilization among Adults with Type 2 Diabetes Mellitus and Concomitant Hypertension and Obesity: A Prospective Survey. Cardiol Res Pract. 2012; 404107. doi:10.1155/2012/ 404107.
  48. Li CY. The incidence and the influencing factors of anxiety and depression in hypertensive patients. Bering: Beijing University of Chinese Medicine. 2013.
  49. Balcı Şengül MC, Kaya V, Şen CA, Kaya K. Association between suicidal ideation and behavior, and depression, anxiety, and perceived social support in cancer patients. Med Sci Monit. 2014; 20: 329-36. doi: 10.12659/MSM.889989.
  50. Kobayashi R, Ishizaki M. Relationship Between Health Literacy and Social Support and the Quality of Life in Patients With Cancer: Questionnaire Study. J Particip Med. 2020; 12: e17163. doi: 10.2196/17163.
  51. Kim MK, Sim JA, Yun YH, Bae DS, Nam JH, Park CT, et al. Health-Related Quality of Life and Sociodemographic Characteristics as Prognostic Indicators of Long-term Survival in Disease-Free Cervical Cancer Survivors. Int J Gynecol Cancer. 2016; 26: 743-9. doi: 10.1097/IGC.0000000000000665.
  52. Carpenter KM, Fowler JM, Maxwell GL, Andersen BL. Direct and buffering effects of social support among gynecologic cancer survivors. Ann Behav Med. 2010; 39: 79-90. doi:10.1007/ s12160-010-9160-1.
  53. Lau Y, Wong DF, Wang Y, Kwong DH, Wang Y. The roles of social support in helping chinese women with antenatal depressive and anxiety symptoms cope with perceived stress. Arch Psychiatr Nurs. 2014; 28: 305-13. doi: 10.1016/j.apnu.2014.05.009.
  54. Vodermaier A, Linden W. Social support buffers against anxiety and depressive symptoms in patients with cancer only if support is wanted: a large sample replication. Support Care Cancer. 2019; 27: 2345-2347. doi: 10.1007/s00520-019-04737-w.
  55. Schroevers MJ, Helgeson VS, Sanderman R, Ranchor AV. Type of social support matters for prediction of posttraumatic growth among cancer survivors. Psychooncology. 2010; 19: 46-53. doi: 10.1002/pon.1501.